Heron Therapeutics, Inc. (HRTX)

NASDAQ: HRTX · Real-Time Price · USD

0.8972

+0.0155 (1.76%)

At close: Mar 16, 2026, 4:00 PM EDT

0.9128

+0.0156 (1.74%)

After-hours: Mar 16, 2026, 5:38 PM EDT

Heron Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	28.65	25.8	28.68	15.36	90.54
Short-Term Investments	17.98	33.48	51.73	69.49	67.04
Cash & Short-Term Investments	46.63	59.28	80.41	84.85	157.58
Cash Growth	-21.34%	-26.27%	-5.24%	-46.15%	-24.42%
Accounts Receivable	89.59	78.88	60.14	52.05	35.5
Inventory	92.75	53.16	42.11	54.57	48.38
Other Current Assets	9.1	17.69	6.12	13.96	12.96
Total Current Assets	238.07	209.01	188.77	205.44	254.42
Net Property, Plant & Equipment	12.4	17.65	25.6	29.81	33.56
Other Long-Term Assets	5.41	6.48	8.13	15.71	17.72
Total Assets	255.88	233.15	222.51	250.95	305.71
Accounts Payable	8.99	11.71	3.24	3.23	3.8
Accrued Expenses	87.1	76.71	73.37	76.44	64.84
Current Portion of Leases	-	3.04	3.08	2.69	2.42
Total Current Liabilities	96.1	91.46	79.69	82.36	71.06
Long-Term Debt	140.64	174.73	173.75	149.28	149.08
Long-Term Leases	-	-	2.8	5.5	8
Other Long-Term Liabilities	4.81	0.62	0.24	0.24	-
Total Long-Term Liabilities	145.45	175.34	176.79	155.02	157.08
Total Liabilities	241.54	266.8	256.48	237.38	228.14
Preferred Stock	1.05	-	-	-	-
Common Stock	1.88	1.52	1.5	1.19	1.02
Additional Paid-in Capital	1,951	1,884	1,871	1,808	1,690
Accumulated Other Comprehensive Income	0	0.01	0.01	-0.02	-0.01
Retained Earnings	-1,940	-1,920	-1,906	-1,795	-1,613
Shareholders' Equity	14.33	-33.65	-33.97	13.57	77.57
Total Liabilities & Equity	255.88	233.15	222.51	250.95	305.71
Total Debt	140.64	177.76	179.63	157.48	159.5
Net Cash (Debt)	-94.01	-118.48	-99.22	-72.63	-1.92
Net Cash Per Share	-0.56	-0.78	-0.72	-0.67	-0.02
Book Value	14.33	-33.65	-33.97	13.57	77.57
Book Value Per Share	0.09	-0.22	-0.25	0.12	0.79
Tangible Book Value	14.33	-33.65	-33.97	13.57	77.57
Tangible Book Value Per Share	0.09	-0.22	-0.25	0.12	0.79

Updated Feb 26, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q